Introduction: The metabolic syndrome according to the IDF (International Diabetes Federation) is at the origin of the double global epidemic of type 2 diabetes and cardiovascular diseases. This work aims to study the metabolic syndrome in the internal medicine department of CHU Point G. Methodology: This was a descriptive study of patients who presented a metabolic syndrome according to the definition of the IDF definition, hospitalized in the internal medicine department of the CHU du point G for the period from January 1 2010 to December 31, 2019. Results: During the study period, 4189 patients were hospitalized, including 60 with metabolic syndrome, representing a hospital frequency of 1.43%. The sex ratio was 0.36. The age group of 50 and 60 years accounted for 28.3%. Forty-six point six percent (46.6%) of our patients were diabetic, 45% obese, 60% hypertensive, 70% sedentary and 10% smokers. Our patients had in 53.3% of cases a blood pressure figure ≥ 130/85 mmHg, abdominal obesity in 100%, hypertriglyceridemia in 33.3%, HDL-C less than 0.40 g/l in 62.5% of men and less than 0.50 g/l in 77.27% of men, blood sugar ≥ 1 g/l in 88.3%. Conclusion: The metabolic syndrome, in view of the entities that compose it, is a real cardiovascular risk factor and therefore a major public health issue.
References
[1]
Dallal, B.C. (2015) The Prevalence of Metabolic Syndrome in Axial Spondy-Loarthritis. Faculty of Medicine and Pharmacy of Fez, Fez.
[2]
Alberti, K.G., Zimmet, P.G., Shaw, J.E. and IDF Epidemiology Task Force Consensus Group (2005) The Metabolic Syndrome—A New Worldwide Definition. Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
[3]
Raoux, F. (2006) Metaboli Csyndrome: Definitions and Epidemiology. MT Cardio, 2, 174 p.
[4]
Cameron, A.J., Shaw, J.E. and Zimmet, P.Z. (2004) The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinology & Metabolism Clinics of North America, 33, 351-375.
[5]
Grundy, R.H., Zimmet, S.M. and Zimmet, P.Z. (2005) The Metabolic Syndrome. Lancet, 365, 1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
[6]
Coste, M. (2006) Prevalence of Metabolic Syndrome in 30-64 Patients during One Month of Consultation. Doctoral Thesis, University of Lyons, Lyons, France.
[7]
Alexander, C.M., Landsman, P.B., Teutsch, S.M. AND Haffner, S.M. (2003) NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease among NHANES III Participants Age 50 Years and Older. Diabetes, 52, 1210-1214. https://doi.org/10.2337/diabetes.52.5.1210
[8]
Smaili, W. (2017) Epidemiological, Clinical and Therapeutic Profile of the Metabolic Syndrome within the GHE Department. Doctoral Thesis, University cadi ayyad, Marrakech.
[9]
Traore, A. (2008) Study on the Metabolic Syndrome in Internal Medicine at the CHU du Point G. Doctoral Thesis , University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali, 67 p.
[10]
Al-Nozha, M., Al-Khadra, A., Arafah, M.R., Al-Maatouq, M.A., Khalil, M.Z., Khan, N.B., et al. (2005) Metabolic Syndrome in Saudi Arabia. Saudi Medical Journal, 12, 1918-1925.